Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis

Clinical trial NCT05979779 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05979779
Sponsor: Rivus Pharmaceuticals, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Alcoholic Fatty Liver Disease Nonalcoholic Steatohepatitis Fatty Liver

Start date: 2023-09-05
Primary completion: 2025-01-21
Enrollment: 219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.